spacer
home > pmps > summer 2007 > agility ability
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Agility Ability

Carl Dugdale at George Group Consulting assesses the competitive advantage of achieving ‘agility’ across the industry

Today, many pharmaceutical organisations are still looking towards mergers to drive increased shareholder value, even though study after study continues to show that long term value is rarely achieved through acquisition – at least not to the acquirer. In our opinion, the most successful long term approach to delivering real value is through organic revenue growth from innovative new products and services. It should be noted that the most successful companies derive 25 per cent or more of their revenue from products or services, which are less than three years old.

To be truly successful, new offers must be differentiated. This can be in terms of product functionality, service offer, target market or any combination of these factors. A great example is Apple’s iPod/iTunes. This combined a radically new physical product with a radically new service design and process, as well as a new market definition. The effect: the redefinition of an entire industry. The result: more value than any imaginable acquisition.

So far, so obvious, you may be thinking. But counter-intuitively, it is not always necessary to be the first-to-market with a new innovation to reap significant commercial rewards. The most critical element is to get to market quickly. Research from the Product Development Institute shows it is the first few entrants who capture high margins, with the late-comers forced to achieve only commodity returns as they compete with multiple providers.

Furthermore, it is critical to meet demand with high quality right from the outset. Second chances to relaunch services or products due to poor quality are fast becoming unaffordable luxuries. And finally, it is critical to be able to rapidly scale to meet rising success and keep followers at bay (1).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
4
     

There are no comments in regards to this article.

spacer
Carl Dugdale is the Senior Vice President and European Managing Director of George Group Consulting. Carl heads George Group’s European operations, advising senior and board-level corporate leaders on major business transformation programmes. Originally trained as a Physicist, with a BSc Hons, Carl gained an MBA from London Business School and keeps up-to-date with short courses at Harvard and Insead.
spacer
Carl Dugdale
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Destiny Pharma appoints MedPharm to develop new XF-platform drug formulations

Destiny Pharma, a clinical stage biotechnology company focused on the development of novel antimicrobial drugs, is pleased to announce that it has appointed MedPharm as its expert partner to develop new topical formulations of the Company’s novel XF-platform compounds. These new treatments for dermal and ocular infections are part of its second clinical programme to address the global problem of anti-microbial resistance (AMR). MedPharm is a world leading contract provider of topical and transdermal product design and formulation development services using sophisticated in vitro models to de-risk development programmes.
More info >>

White Papers

Spotlight on Quality in Study Startup

Oracle Health Sciences

This white paper addresses the growing interest in quality in clinical trial execution and how workflows play an essential role by building in the steps needed to comply with TMF guidelines, reducing downstream problems. This proactive strategy limits issues caused by siloes, yielding process improvements measurable by performance metrics.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement